Skip to main content
. Author manuscript; available in PMC: 2007 Apr 30.
Published in final edited form as: Synapse. 1995 Jan;19(1):56–65. doi: 10.1002/syn.890190108

TABLE I.

Microdialysis studies of amphetamine-stimulated DA release in amphetamine-sensitized rats

Amphetamine treatment Withdrawal (days) Challenge (mgkg) Effect Reference
Escalatine, 1 → 10 mdke 2/d × 6 weekl,d-AMP 30-60 1.5 ↑ (Acc&Cau) Robinson, 1991
Escalating, 1→ 10 mgkg 2/d → 6 weeks, d-AMP 28 0.5 ↑ (Acc & Cau) Present study
Escalating, 1 → 10 mgkg 2/d ×6 weeks, d-AMP 15-2 1 2.0 ↑ (Acc) Robinson et al., 1988
5/mgkg 2/d → 5d, d-AMP 15 0.5 ↑(Cau) Patrick et al., 1991
2.5 μg × 3 (intra-acc d-AMP) 14 1.0 (i.p.) ↑(Acc) Vezina, 1993
1 mgkg l/d × 10d, d-AMP 10-14 0.5 ↑ (Acc) Wolf et al., 1993
4 mgkg l/d × 14d, meth-AMP 7 4.0 ↑(Cau) Kazahaya et al., 1989
Escalating, 1 → 10 mgkg 2/d × 6 weeks, d-AMP 7 0.5 --(Acc & Cau) Present study
2.5-3.0 mgkg l/d × 4-6d, d-AMP 2-6 2.5 ↓ (Acc & Cau) Segal and Kuczenski, 1992
1 mgkg l/d × 10d, d-AMP 3-4 0.5 --(Act) Wolf et al., 1993
Escalating, 1 → 10 mgkg 2/d × 6 weeks, d-AMP 3 0.5 --(ACC & Cau) Present study
HHS Vulnerability Disclosure